Showing results (1-10 of 326) with videos related to
Sort By:
Pageof 33
Immunotherapy|November 8, 2011
Cytokine blockade in inflammatory bowel diseasesClémentine Perrier, Paul RutgeertsDigestive Diseases (Basel, Switzerland)|October 19, 2012
New drug therapies on the horizon for IBDClémentine Perrier, Paul RutgeertsInflammatory Bowel Diseases|June 1, 2012
Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitisClémentine Perrier, Gert de Hertogh, Jonathan Cremer, et al.The Journal of Biological Chemistry|March 18, 2006
Glycans on secretory component participate in innate protection against mucosal pathogensClémentine Perrier, Norbert Sprenger, Blaise CorthésyInflammatory Bowel Diseases|February 16, 2010
Effects of T cell-induced colonic inflammation on epithelial barrier functionPeter Suenaert, Philippe Maerten, Gert Van Assche, et al.Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Strategies in the prevention of post-operative recurrence in Crohn's diseasePaul RutgeertsJournal of Gastroenterology and Hepatology|May 10, 2002
A critical assessment of new therapies in inflammatory bowel diseasePaul RutgeertsDigestive Diseases (Basel, Switzerland)|July 17, 2012
How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?Paul RutgeertsImmunology|October 9, 2012
Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximabClémentine Perrier, Ingrid Arijs, Dominiek Staelens, et al.The Journal of Biological Chemistry|April 13, 2007
Solution structure of human secretory component and implications for biological functionAlexandra Bonner, Clémentine Perrier, Blaise Corthésy, et al.Pageof 33